$18.82 0.18 (+0.97%)
12/4/2009 11:17 AM

Pfizer, Inc. (PFE)

CAPS Rating: 4 out of 5

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

Recs

0
Member Avatar rockambo (48.46) Submitted: 12/5/2008 1:36:48 PM : Underperform Start Price: $15.29 PFE Score: +13.12

so lots of good things are happen to this company, but they haven't recovered from the blockbuster business model and there's about one potential drug in the pipeline and a whole lot of expiring patents. Longterm I see growth, shortterm, lots of pain medication and suffering.

Report this Post 0 Comments

Featured Broker Partners